{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:11:31Z","timestamp":1788876691938,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52273299"],"award-info":[{"award-number":["52273299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515012317"],"award-info":[{"award-number":["2024A1515012317"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515011884"],"award-info":[{"award-number":["2023A1515011884"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20250604144930041"],"award-info":[{"award-number":["JCYJ20250604144930041"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220531102207016"],"award-info":[{"award-number":["JCYJ20220531102207016"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20241202124709013"],"award-info":[{"award-number":["JCYJ20241202124709013"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["KCXFZ20230731092802004"],"award-info":[{"award-number":["KCXFZ20230731092802004"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009019","name":"Shenzhen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bcp.2026.118433","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:25:51Z","timestamp":1788503151000},"page":"118433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Dual GPX4\/PARP inhibitor YHD-26 exerts potent antitumor activity against triple-negative breast cancer via ferroptosis and DNA damage synergy"],"prefix":"10.1016","volume":"254","author":[{"given":"Honglei","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yupei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhendan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4544-752X","authenticated-orcid":false,"given":"Dahong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118433_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","article-title":"Pathogenesis of triple-negative breast cancer","volume":"17","author":"Derakhshan","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"4","key":"10.1016\/j.bcp.2026.118433_b0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26041396","article-title":"Divide and conquer-targeted therapy for triple-negative breast cancer","volume":"26","author":"Nedeljkovi\u0107","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.bcp.2026.118433_b0015","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.bcp.2026.118433_b0020","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.2011.38.2010","article-title":"Dissecting the heterogeneity of triple-negative breast cancer","volume":"30","author":"Metzger-Filho","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bcp.2026.118433_b0025","doi-asserted-by":"crossref","DOI":"10.4274\/ejbh.galenos.2025.2024-10-2","article-title":"Prognostic significance and molecular classification of triple negative breast cancer: a systematic review","author":"Dogra","year":"2025","journal-title":"Eur. J. Breast Health"},{"issue":"8","key":"10.1016\/j.bcp.2026.118433_b0030","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/jcp.31015","article-title":"Triumphs and challenges in exploiting poly(ADP-ribose) polymerase inhibition to combat triple-negative breast cancer","volume":"238","author":"Wooten","year":"2023","journal-title":"J. Cell. Physiol."},{"issue":"6330","key":"10.1016\/j.bcp.2026.118433_b0035","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.bcp.2026.118433_b0040","doi-asserted-by":"crossref","unstructured":"P.-B. Kanev, A. Atemin, S. Stoynov, R. Aleksandrov, PARP1 roles in DNA repair and DNA replication: the basi(c)s of PARP inhibitor efficacy and resistance, Seminars Oncol., 51(1) (2024) 2-18.https:\/\/doi.org\/10.1053\/j.seminoncol.2023.08.001.","DOI":"10.1053\/j.seminoncol.2023.08.001"},{"issue":"14","key":"10.1016\/j.bcp.2026.118433_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141904","article-title":"Unravelling the role of PARP1 in homeostasis and tumorigenesis: implications for anti-cancer therapies and overcoming resistance","volume":"12","author":"Lovsund","year":"2023","journal-title":"Cells"},{"issue":"14","key":"10.1016\/j.bcp.2026.118433_b0050","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181062","article-title":"BRCAness, DNA gaps, and gain and loss of PARP inhibitor-induced synthetic lethality","volume":"134","author":"Li","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118433_b0055","article-title":"A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors","author":"Hage Chehade","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bcp.2026.118433_b0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12943-020-01227-0","article-title":"PARP inhibitor resistance: the underlying mechanisms and clinical implications","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Cancer"},{"issue":"21","key":"10.1016\/j.bcp.2026.118433_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115907","article-title":"Targeting the DNA damage response for cancer therapy","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"25","key":"10.1016\/j.bcp.2026.118433_b0070","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa2105215","article-title":"Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer","volume":"384","author":"Tutt","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.bcp.2026.118433_b0075","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s43018-022-00400-2","article-title":"Neoadjuvant study of niraparib in patients with HER2-negative BRCA-mutated, resectable breast cancer","volume":"3","author":"Spring","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bcp.2026.118433_b0080","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.2147\/CMAR.S316470","article-title":"Patterns and prevalence of BRCA1 and BRCA2 germline mutations among patients with triple-negative breast cancer: regional perspectives","volume":"13","author":"Abdel-Razeq","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"4","key":"10.1016\/j.bcp.2026.118433_b0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/s41388-024-03227-6","article-title":"Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms","volume":"44","author":"Jain","year":"2025","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bcp.2026.118433_b0090","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/2159-8290.CD-11-0348","article-title":"PI3K inhibition impairs BRCA1\/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition","volume":"2","author":"Ibrahim","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2026.118433_b0095","doi-asserted-by":"crossref","unstructured":"A.K. Mehta, E.M. Cheney, C.A. Hartl, C. Pantelidou, M. Oliwa, J.A. Castrillon, J.R. Lin, K.E. Hurst, M. de Oliveira Taveira, N.T. Johnson, W.M. Oldham, M. Kalocsay, M.J. Berberich, S.A. Boswell, A. Kothari, S. Johnson, D.A. Dillon, M. Lipschitz, S. Rodig, S. Santagata, J.E. Garber, N. Tung, J. Y\u00e9lamos, J.E. Thaxton, E.A. Mittendorf, P.K. Sorger, G.I. Shapiro, J.L. Guerriero, Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer, Nat. Cancer 2(1) (2021) 66-82.10.1038\/s43018-020-00148-7.","DOI":"10.1038\/s43018-020-00148-7"},{"issue":"1","key":"10.1016\/j.bcp.2026.118433_b0100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-024-01564-3","article-title":"Ferroptosis: principles and significance in health and disease","volume":"17","author":"Chen","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"18","key":"10.1016\/j.bcp.2026.118433_b0105","doi-asserted-by":"crossref","first-page":"22403","DOI":"10.1021\/acsami.3c01350","article-title":"A carrier-free nanomedicine enables apoptosis-ferroptosis synergistic breast cancer therapy by targeting subcellular organelles","volume":"15","author":"Zhu","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bcp.2026.118433_b0110","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.02.015","article-title":"Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs","volume":"483","author":"Su","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bcp.2026.118433_b0115","doi-asserted-by":"crossref","unstructured":"S. Hussain, G. Gupta, M. Shahwan, P. Bansal, H. Kaur, M. Deorari, K. Pant, H. Ali, S.K. Singh, V.S. Rama Raju Allam, K.R. Paudel, K. Dua, V. Kumarasamy, V. Subramaniyan, Non-coding RNA: a key regulator in the Glutathione-GPX4 pathway of ferroptosis, Noncoding RNA Res 9(4) (2024) 1222-1234.10.1016\/j.ncrna.2024.05.007.","DOI":"10.1016\/j.ncrna.2024.05.007"},{"key":"10.1016\/j.bcp.2026.118433_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117015","article-title":"A prospective therapeutic strategy: GPX4-targeted ferroptosis mediators","volume":"281","author":"Qian","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.118433_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115866","article-title":"Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer","volume":"169","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118433_b0130","doi-asserted-by":"crossref","unstructured":"J. Liu, R. Kang, D. Tang, Adverse effects of ferroptotic therapy: mechanisms and management, Trends in Cancer 10(5) (2024) 417-429.https:\/\/doi.org\/10.1016\/j.trecan.2024.01.002.","DOI":"10.1016\/j.trecan.2024.01.002"},{"issue":"5","key":"10.1016\/j.bcp.2026.118433_b0135","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41589-020-0501-5","article-title":"Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles","volume":"16","author":"Eaton","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2026.118433_b0140","article-title":"GPX4 inhibition enhances the antitumor effect of PARP inhibitor on homologous recombination proficient ovarian cancer cells","author":"Gu","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.bcp.2026.118433_b0145","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.redox.2018.03.016","article-title":"Increased oxidative stress mediates the antitumor effect of PARP inhibition in ovarian cancer","volume":"17","author":"Hou","year":"2018","journal-title":"Redox Biol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118433_b0150","doi-asserted-by":"crossref","first-page":"e3070","DOI":"10.1038\/cddis.2017.471","article-title":"Berberine induces oxidative DNA damage and impairs homologous recombination repair in ovarian cancer cells to confer increased sensitivity to PARP inhibition","volume":"8","author":"Hou","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2026.118433_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.610205","article-title":"Alkannin-Induced oxidative DNA damage synergizes with PARP inhibition to cause cancer-specific cytotoxicity","volume":"11","author":"Chang","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118433_b0160","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1039\/C7OB03086J","article-title":"Small-molecule anticancer agents kill cancer cells by harnessing reactive oxygen species in an iron-dependent manner","volume":"16","author":"Fedorka","year":"2018","journal-title":"Org. Biomol. Chem."},{"issue":"21","key":"10.1016\/j.bcp.2026.118433_b0165","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1021\/acs.jmedchem.2c01276","article-title":"First-in-class dual mechanism ferroptosis-HDAC inhibitor hybrids","volume":"65","author":"Karaj","year":"2022","journal-title":"J. Med. Chem."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226007720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:55:19Z","timestamp":1788875719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226007720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S0006295226007720"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118433","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual GPX4\/PARP inhibitor YHD-26 exerts potent antitumor activity against triple-negative breast cancer via ferroptosis and DNA damage synergy","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118433"}}